GYRE icon

Gyre Therapeutics
GYRE

Overview Fund Activity

65 hedge funds and large institutions have $59.3M invested in Gyre Therapeutics in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-5
Holders Change %
-7.14%
% of All Funds
1.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
24
Reduced
20
Closed
15
Calls
$554K
Puts
$401K
Net Calls
+$153K
Net Calls Change
+$2.88M

Top Buyers

1
NCM
1
Nantahala Capital Management
Connecticut
$6.75M
2
PM
2
Prosight Management
Texas
$3.68M
3
Assenagon Asset Management
3
Assenagon Asset Management
Luxembourg
$1.62M
4
2L
4
22NW LP
Washington
$1.12M
5
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$4.01M

Top Sellers

1
NC
1
Nexthera Capital
New York
$2.97M
2
GCP
2
GSA Capital Partners
United Kingdom
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.91M
4
SCM
4
Sio Capital Management
New York
$2.3M
5
Renaissance Technologies
5
Renaissance Technologies
New York
$1.57M
Name Holding Trade Value Shares
Change 		Shares
Change %
TRCT
76
Tower Research Capital (TRC)
New York
– -$10K -124 Closed
Group One Trading
77
Group One Trading
Illinois
– -$9K -113 Closed
Royal Bank of Canada
78
Royal Bank of Canada
Ontario, Canada
– -$2K -31 Closed
Federated Hermes
79
Federated Hermes
Pennsylvania
– -$2K -23 Closed
1 2 3
4